CHICAGO, November 12, 2019-- Apervita, the leading platform for value-based collaboration in healthcare, today announced that it secured $22 million in incremental investment to further accelerate its growth. The announcement comes on the heels of the merger between Apervita and Qcentive and the appointment of industry veteran Kevin Hutchinson as CEO, both of which occurred in the third quarter of 2019. "I'm thrilled to have partnered with our board of directors and current investors to secure the necessary capital for this next phase of Apervita," Hutchinson said.